Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655642 · ClinicalTrials.gov registry record · NA
Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED
A NA study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- NA
- Development phase
- 171
- Enrollment target
NCT00655642 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 171 participants.
The verdict
NCT00655642, a NA study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of ondansetron, metoclopramide, and promethazine for the treatment of nausea in the adult emergency department population. We hypothesize that a single intravenous dose of ondansetron is more effective in reducing nausea than a single IV dose of metoclopramide, promethazine or normal saline placebo in undifferentiated adult emergency department patients.
Interventions
- DRUG Ondansetron
- DRUG Normal Saline
- DRUG Metoclopramide
- DRUG Promethazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655642
The ClinicalTrials.gov registry entry for NCT00655642 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ondansetron is the first listed.
NCT00655642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655642 about?
NCT00655642 is a clinical study titled "Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED". The purpose of this study is to compare the effectiveness of ondansetron, metoclopramide, and promethazine for the treatment of nausea in the adult emergency department population. We hypothesize that a single intravenous dose of ondansetron is more effective in reducing nausea than a single IV dos...
What is the current status of trial NCT00655642?
This trial is currently terminated. It is a NA study. The enrollment target is 171 participants. The study started on 2007-03. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00655642?
The interventions under investigation include: Ondansetron (DRUG), Normal Saline (DRUG), Metoclopramide (DRUG), Promethazine (DRUG).
Who is sponsoring clinical trial NCT00655642?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.